2006
DOI: 10.1055/s-2006-951608
|View full text |Cite
|
Sign up to set email alerts
|

Dyskinesia during Treatment with Duloxetine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
16
1

Year Published

2007
2007
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 22 publications
(18 citation statements)
references
References 9 publications
1
16
1
Order By: Relevance
“…Common adverse effects include dry mouth, nausea, insomnia, somnolence, dizziness and constipation. Reported adverse effects of EPS are rare 4,5…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Common adverse effects include dry mouth, nausea, insomnia, somnolence, dizziness and constipation. Reported adverse effects of EPS are rare 4,5…”
Section: Introductionmentioning
confidence: 99%
“…Although, it is believed that the dystonia results from the abnormality of the basal ganglia, the pathophysiology of acute dystonia is not clear yet. However, a few cases of duloxetine induced dystonia are reported in the literature 5-7. In this case, a patient who suffered from a neck spasm and pain which woke her up from sleep, dystonic distortion of the neck, tremor in her hands and lips after only one dose of 30 mg duloxetine is presented.…”
Section: Introductionmentioning
confidence: 99%
“…Further overdose cases were encountered during premarketing clinical trials, where four cases of overdose were reported. The minimum ingestion of duloxetine was 300 mg while the highest reported ingestion was approximately 1400 mg. 31 All patients survived the overdose event.…”
Section: Discussionmentioning
confidence: 98%
“…30 As such, co-administration of medications that are predominantly metabolized by CYP 2D6 which have a narrow therapeutic index should be undertaken with caution. 31 Co-administration of duloxetine with paroxetine (a CYP 2D6 inhibitor) resulted in an average AUC increase in duloxetine of 160%, however, the paroxetine dosages used in the assessment were low (20 mg) and not at steady state, and the duloxetine doses were 40 mg per day. Consequently, with maximal paroxetine dosing under steady-state conditions, the extent of duloxetine exposure would be expected to be even larger, and would be compounded by the higher doses of duloxetine that typify clinical usage.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation